Study of etiologies of postmenopausal bleeding by cytology and histopathological examination
DOI:
https://doi.org/10.18203/2320-6012.ijrms20252174Keywords:
Postmenopausal bleeding, Cervical cancer, Endometrial hyperplasia, Cytology, HistopathologyAbstract
Background: Postmenopausal bleeding (PMB) is a common gynecologic complaint with a wide range of benign and malignant etiologies. While atrophic changes are the most frequent benign causes, PMB may also be the earliest sign of gynecological malignancies such as cervical and endometrial cancer, particularly in low-resource settings where screening uptake is low. Aim lies to determine the etiologies of PMB using cytological and histopathological evaluation and identify the most common associated factors, particularly those indicating malignant potential.
Methods: A hospital-based cross-sectional study was conducted at Rajendra institute of medical sciences (RIMS), Ranchi, from April 2021 to August 2022. A total of 76 postmenopausal women presenting with vaginal bleeding were included. Detailed histories, clinical examinations, pap smear, transvaginal ultrasonography (TVS), and endometrial or cervical biopsies were performed. Histopathological findings were considered the definitive diagnosis. Data were analyzed using SPSS version 23.0, and associations were tested using chi square test and odds ratios (ORs) with 95% confidence intervals (CIs); a p<0.05 was considered significant.
Results: The most common age group affected was 51-60 years (47.4%). Histopathological diagnoses revealed cervical cancer in 30.3% of cases, followed by atrophic endometrium (23.7%), cervical intraepithelial neoplasia (CIN) (23.7%), endometrial hyperplasia (10.5%), and endometrial cancer (6.6%). A significant association was found between low socioeconomic status and cervical cancer (p=0.03, OR=4.33). Early childbirth (≤19 years) was significantly associated with CIN (p=0.03, OR=3.14). Parity of 0-4 was associated with endometrial hyperplasia (p=0.03). Pap smear results correlated well with histopathological findings in high-grade lesions and malignancies.
Conclusions: Cervical cancer remains the leading malignant cause of PMB, especially among women of low socioeconomic background. Atrophy and endometrial hyperplasia are significant benign causes. Cytology and histopathological examination remain essential tools for evaluating PMB, particularly in resource-limited settings.
Metrics
References
Munro MG, Critchley HO, Fraser IS. The FIGO classification of causes of abnormal uterine bleeding. Int J Gynaecol Obstet. 2019;144(3):343-6.
Goldstein SR. Postmenopausal bleeding: evaluation and management. Clin Obstet Gynecol. 2020;63(4):688-98.
Merrill JA. Management of postmenopausal bleeding. Clin Obstet Gynecol. 1981;24(1):285-99. DOI: https://doi.org/10.1097/00003081-198103000-00024
Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Global Health. 2020;8(2):e191-203. DOI: https://doi.org/10.1016/S2214-109X(19)30482-6
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer J Clin. 2021;71(3):209-49. DOI: https://doi.org/10.3322/caac.21660
Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Int J Gynecol Cancer. 2016;26(1):2-30. DOI: https://doi.org/10.1097/IGC.0000000000000609
Karlsson B, Granberg S, Wikland M, Ylöstalo P, Torvid K, Marsal K, et al. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding-a Nordic multicenter study. Am J Obstetr Gynecol. 1995;172(5):1488-94. DOI: https://doi.org/10.1016/0002-9378(95)90483-2
Denny L, de Sanjosé S, Mutebi M, et al. Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries. Lancet. 2019;393(10171):861-70. DOI: https://doi.org/10.1016/S0140-6736(16)31795-0
Clarke MA, Fetterman B, Cheung LC, Jessica L, Christopher CS, Barbara F, et al. HPV DNA methylation as a biomarker for cervical cancer screening: recent advances. J Pathol. 2020;250(4):378-86.
Ajmera S, Gupta SR, Ajmera R. Diagnostic efficacy of endometrial aspiration cytology with histopathological correlation. Int J Med Biomed Stud. 2021;5(7):91-5. DOI: https://doi.org/10.32553/ijmbs.v5i7.1997
O'Flynn H, Ryan N, Narine N, Shelton D, Rana D, Crosbie E. Diagnostic accuracy of cytology for the detection of endometrial cancer in urine and vaginal samples. Nat Commun. 2021;12:1-11. DOI: https://doi.org/10.1038/s41467-021-21257-6
Yang X, Ma K, Chen R, Meng Y, Wen J, Zhang Q, et al. A study evaluating liquid-based endometrial cytology test and transvaginal ultrasonography as a screening tool for endometrial cancer in 570 postmenopausal women. J Gynecol Obstet Hum Reprod. 2023;52(8):102643. DOI: https://doi.org/10.1016/j.jogoh.2023.102643
Lakhey A, Priyadarsinee A, Regmi S, Acharya S. Histopathological findings in postmenopausal bleeding. Med Phoenix. 2023;8(1):13-8. DOI: https://doi.org/10.3126/medphoenix.v8i1.56924
Kılıççı Ç, Cogendez E, Kumru P, Ergen EB, Koç N, Yayla CA. Cytological assessment of endometrial washings using a liquid-based method for detecting endometrial pathologies. Arch Gynecol Obstet. 2018;298(1):171-7. DOI: https://doi.org/10.1007/s00404-018-4788-3
Mokbel A. Endometrial flushing versus endometrial brush cytology in high-risk women for endometrial carcinoma. Ain Shams Med J. 2020;71(1):137-42. DOI: https://doi.org/10.21608/aimj.2020.68889
Downloads
Published
How to Cite
Issue
Section
